Thus, the three potential diagnostic biomarkers, NAGS, HDHD3 and RMND1, may primarily contribute to NAFLD via involvement in aberrant fatty acid/bile acid metabolism. The gene discussed is HDHD3; the disease is metabolic dysfunction-associated steatotic liver disease.